Evaluation of amlodipine passage into breast milk in patients with pregnancy-induced hypertension

Evaluation of amlodipine passage into breast milk in patients with pregnancy-induced hypertension - Evaluation of amlodipine passage into breast milk in patients with pregnancy-induced hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013632

Enrollment

Registered

2014-04-04

Start date

2011-04-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy-induced hypertension

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Patients receiving oral amlodipine for pregnancy-induced hypertension 2.Patients receiving written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients discontinued oral amlodipine 2.Pregnancy women

Design outcomes

Primary

Measure	Time frame
Plasma and milk concentration of amlodipine	—

Secondary

Measure	Time frame
Relative infant dose of amlodipine Factors determining the plasma exposre of amlodipine	—

Countries

Japan

Contacts

Public ContactTakafumi Naito

Hamamatsu University School of Medicine Department of Hospital Pharmacy

pharmacyham-adm@umin.ac.jp053-435-2623

Outcome results